Improving HIV prevention for high-risk adults in East Africa who drink alcohol
Mentorship in patient-oriented research to optimize community-based HIV prevention for adults at high-risk of HIV at alcohol drinking venues in East Africa
This study is all about finding better ways to help adults at high risk of HIV, especially those who often visit bars, in East Africa, by creating friendly and effective ways to encourage them to get involved in HIV prevention and treatment while also tackling issues like heavy drinking.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10901942 on NIH RePORTER |
What this research studies
This research focuses on enhancing community-based HIV prevention strategies for adults at high risk of HIV, particularly those who frequent alcohol drinking venues in East Africa. The project aims to develop effective methods for engaging these individuals in HIV prevention and treatment, addressing barriers such as unhealthy alcohol use. The principal investigator, Dr. Gabriel Chamie, will also mentor early-stage researchers to expand the impact of this work. By fostering a mentorship program, the research seeks to create sustainable solutions for reaching populations that often avoid medical care.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who frequently consume alcohol and are at high risk for HIV.
Not a fit: Patients who do not consume alcohol or are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce HIV transmission rates among high-risk populations in East Africa.
How similar studies have performed: Previous research has shown success in community-based HIV prevention strategies, particularly when addressing specific high-risk behaviors.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Chamie, Gabriel — University of California, San Francisco
- Study coordinator: Chamie, Gabriel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.